Nizoral (Ketoconazole)

Ketoconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of fungal cell membranes. By blocking ergosterol production, the drug compromises membrane integrity, leading to impaired fungal growth and eventual cell death of susceptible organisms.

The specific dose and frequency of Nizoral are determined by the prescribing healthcare professional based on the condition being treated, the patient’s age, and the product’s formulation. Patients should follow the prescriber’s instructions and the product label for optimal results.

Safety data for topical ketoconazole during pregnancy or lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing Nizoral to pregnant or nursing individuals. Consultation with a medical professional is essential.

To order Nizoral, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Nizoral’s ketoconazole formulation offers broad‑spectrum activity against yeasts and dermatophytes, making it effective for several common skin infections. Compared with allylamine agents such as terbinafine, ketoconazole may have a slightly slower onset but is useful for conditions where inflammation is prominent, like seborrheic dermatitis.

Store Nizoral at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and extreme heat. Ensure the container is tightly closed when not in use to maintain product stability.

Apply a thin layer of Nizoral to the affected skin or scalp area, gently massaging it into the skin or hair. Follow the prescriber’s directions regarding frequency, typically once or twice daily, and continue use for the full course even if symptoms improve early.

While most reactions are mild, serious risks include severe allergic responses such as angioedema, anaphylaxis, or extensive contact dermatitis. If any signs of swelling, difficulty breathing, or widespread rash develop, discontinue use immediately and seek emergency medical attention.

Individuals with known hypersensitivity to ketoconazole or any component of the formulation should avoid Nizoral. It should also be used with caution on broken or inflamed skin, and patients with liver disease should consult a physician before using systemic ketoconazole products.